EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
2.190
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
EDAP TMS Revenue
EDAP TMS had revenue of 13.10M EUR in the quarter ending September 30, 2024, with 11.60% growth. This brings the company's revenue in the last twelve months to 63.41M, up 12.17% year-over-year. In the year 2023, EDAP TMS had annual revenue of 60.42M with 9.64% growth.
Revenue (ttm)
63.41M EUR
Revenue Growth
+12.17%
P/S Ratio
1.15
Revenue / Employee
206,547 EUR
Employees
307
Market Cap
81.26M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 60.42M | 5.31M | 9.64% |
| Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
| Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
| Dec 31, 2020 | 41.66M | -3.25M | -7.24% |
| Dec 31, 2019 | 44.91M | 5.73M | 14.62% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 23andMe Holding Co. | 193.26M |
| Karyopharm Therapeutics | 148.44M |
| bluebird bio | 53.12M |
| Aadi Bioscience | 25.07M |
| Generation Bio Co. | 18.58M |
| Adlai Nortye | 5.00M |
EDAP News
- 17 days ago - Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer - GlobeNewsWire
- 4 weeks ago - EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis - GlobeNewsWire
- 6 weeks ago - EDAP TMS S.A. (EDAP) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 3 months ago - EDAP and Avenda Health Launch World's First AI-Assisted Focal One® Robotic HIFU Procedures - GlobeNewsWire
- 4 months ago - EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - EDAP TMS S.A. (EDAP) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - EDAP Reports Second Quarter 2024 Financial Results - GlobeNewsWire